Lymphohistiocytosis in the brain
Recognition of a potentially reversible aspect of primary HLH
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In this issue of Neurology®, Deiva et al.1 describe the CNS features of primary hemophagocytic lymphohistiocytosis (HLH), a rare genetic immunodeficiency disorder associated with macrophage activation. Microcephaly, seizures, encephalopathy, abnormal spinal fluid (elevated protein, cellularity, or more specifically, hemophagocytosis), and periventricular white matter lesions characterize the CNS features of HLH, with progressive cognitive decline occurring in surviving, nontransplanted children. Of 46 children with HLH, 63% had abnormal neurologic examination, 50% had abnormal spinal fluid, and 33% had abnormal brain MRI.
Encephalopathy, multifocal neurologic deficits, and young age at onset renders challenging the distinction of HLH from acute disseminated encephalomyelitis (ADEM). Deiva et al. specifically compared the MRI features of the 46 children with HLH to those of 44 children with ADEM. Although both HLH and ADEM are characterized by bilateral, multifocal areas of increased T2 signal, the lesion distribution of HLH preferentially involved the periventricular white matter, and rarely involved the deep gray nuclei or brainstem. Although none of the MRI features were absolutely discriminatory, the relative involvement and symmetric nature …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
CNS involvement at the onset of primary hemophagocytic lymphohistiocytosisK. Deiva, N. Mahlaoui, F. Beaudonnet et al.Neurology, March 14, 2012 -
Article
Pediatric CNS-isolated hemophagocytic lymphohistiocytosisLeslie A. Benson, Hojun Li, Lauren A. Henderson et al.Neurology: Neuroimmunology & Neuroinflammation, April 08, 2019 -
Articles
Differential diagnosis and evaluation in pediatric multiple sclerosisJin S. Hahn, Daniela Pohl, Mary Rensel et al.Neurology, April 16, 2007 -
Clinical/Scientific Notes
Progressive neurologic disorder: Initial manifestation of hemophagocytic lymphohistiocytosisClaire Murphy, Sira Nanthapisal, Kimberly Gilmour et al.Neurology, April 29, 2016